<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200122046228N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-28</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>The effect of  computerized stress inoculation therapy (SIT) vs Part-time face-to-face SIT on anxiety , depression , and stress in pregnant women</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of effectiveness of computerized stress inoculation therapy (SIT) with Part-time face-to-face SIT in improvement of symptoms of anxiety, depression and stress in pregnant women with psychological distress</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>96</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50493</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After checking inclusion and exclusion criteria, participants are allocate randomly into two groups by permuted block randomization method. The block size is 4 and by using the statistical software, 4 part blocks will be produced 24 times. Due to the fact that sampling is done in two centers, two samples of 96-list will be produced. Using this randomly generated list, participants are divided into two groups of 48 people.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Anxiety, depression, and stress.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The participants in this group at 14 to 34 weeks of pregnancy in addition to receiving prenatal care, receive computerized Stress Inoculation Therapy (SIT), 6 session , 60 minutes, once a week. Content of SIT: Session 1: Introducing and explaining the goals, describing the symptoms and their effects on mother and baby, conceptualizing the problem, explaining how this method reduces distress and anxiety. Session 2: Teaching body relaxation and continuing these exercises at home in Intervals between sessions,  Session 3: Relaxing the body, challenging stressful thoughts, learning to talk to yourself and identifying the role of negative thoughts in creating these feelings, assign homework and practice body relaxation at home. Session 4: Body relaxation, teaching problem solving skills, assigning tasks, and practicing body relaxation at home, Session 5: Relaxation of the body, training techniques of concentration and distraction of the mind, away from unsolvable stressful issues, assigning homework and practicing body relaxation at home, Session 6: Practicing the skills learned in previous sessions in the training session and then gradually in real life events, especially in stressful situations. Intervention 2: Intervention group 2: The participants in this group at 14 to 34 weeks of pregnancy in addition to receiving prenatal care, receive individually Part-time face-to-face stress inoculation therapy, 6 sessions, 60 minutes, once a week. They receive treatment sessions with 3 face-to-face sessions and 3 computer sessions as one in between. Content and duration of treatment for both groups is similar, 6 sessions, once a week for 60 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Nasiri- Amiri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Midwifery, School of Medicine, Babol University of Medical Sciences, Ganj Afrooz St., Babol, Iran</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4717647745</zip>
        <telephone>+98 11 3219 0597</telephone>
        <email>nasiri_fa@yahoo.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Nasiri- Amiri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Midwifery, School of Medicine, Babol University of Medical Sciences, Ganj Afrooz St., Babol, Iran</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4717647745</zip>
        <telephone>+98 11 3219 0597</telephone>
        <email>nasiri_fa@yahoo.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness to participate in the study
Being in the 14th-32nd week of pregnancy
No current psychotherapy services
Lack of a history of psychiatric  disorder
At least a third year of middle school
Internet access and the ability to use of computer</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>People with mental disabilities
Severe psychiatric disorders such as Psychotic disorder, Bipolar disorder, Suicide risk,
Drug abuse</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mixed anxiety and depressive disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The participants in this group at 14 to 34 weeks of pregnancy in addition to receiving prenatal care, receive computerized Stress Inoculation Therapy (SIT), 6 session , 60 minutes, once a week. Content of SIT: Session 1: Introducing and explaining the goals, describing the symptoms and their effects on mother and baby, conceptualizing the problem, explaining how this method reduces distress and anxiety. Session 2: Teaching body relaxation and continuing these exercises at home in Intervals between sessions,  Session 3: Relaxing the body, challenging stressful thoughts, learning to talk to yourself and identifying the role of negative thoughts in creating these feelings, assign homework and practice body relaxation at home. Session 4: Body relaxation, teaching problem solving skills, assigning tasks, and practicing body relaxation at home, Session 5: Relaxation of the body, training techniques of concentration and distraction of the mind, away from unsolvable stressful issues, assigning homework and practicing body relaxation at home, Session 6: Practicing the skills learned in previous sessions in the training session and then gradually in real life events, especially in stressful situations</i_keyword>
      <i_keyword>Intervention group 2: The participants in this group at 14 to 34 weeks of pregnancy in addition to receiving prenatal care, receive individually Part-time face-to-face stress inoculation therapy, 6 sessions, 60 minutes, once a week. They receive treatment sessions with 3 face-to-face sessions and 3 computer sessions as one in between. Content and duration of treatment for both groups is similar, 6 sessions, once a week for 60 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety, depression, somatization, pregnancy-specific stress. Timepoint: Before the intervention and immediately after the intervention. Method of measurement: Anxiety and depression and somatization with Brief Symptom Inventory–18  (BSI-18) pregnancy-specific stress questionnaire ( NuPDQ-17) for pregnancy-specific stress.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>General perceived stress. Timepoint: Before the intervention and immediately after the intervention. Method of measurement: Cohen General Perceived Stress Questionnaire (PSS-14).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-23</approval_date>
        <contact_name>Ethics Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Ganj Afrooz St., Babol University of Medical Sciences Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
